We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
-4.54%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$21.9M
(+1%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
6.52%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
387
New
13
Increased
178
Reduced
139
Closed
14
Avg Time Held
5.5
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional International Core Equity Market ETF
DFAI
|
+$30.3M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$24.2M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$23.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$13.8M |
| 5 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$16.8M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$4.06M |
| 3 |
Northrop Grumman
NOC
|
+$2.81M |
| 4 |
Leidos
LDOS
|
+$2.15M |
| 5 |
Saic
SAIC
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.91% |
| 2 | Technology | 10.65% |
| 3 | Healthcare | 9.36% |
| 4 | Financials | 6.57% |
| 5 | Consumer Staples | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Avantis Emerging Markets Equity ETF
AVEM
$27.3B
| $364K | 0.02% |
+7,932
| New | +$404K |
2022 Q3
0 quarters
|
|
302
Clorox
CLX
$10.4B
| $362K | 0.02% |
2,823
-57
| -2% | -$8.22K |
2013 Q2
37 quarters
|
|
303
Edwards Lifesciences
EW
$50.8B
| $359K | 0.02% |
4,343
+78
| +2% | +$7.5K |
2020 Q2
9 quarters
|
|
304
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
| $359K | 0.02% |
+7,151
| New | +$358K |
2022 Q3
0 quarters
|
|
305
Linde
LIN
$227B
| $355K | 0.02% |
1,318
+33
| +3% | +$9.48K |
2021 Q4
3 quarters
|
|
306
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
| $346K | 0.02% |
2,839
+329
| +13% | +$44.5K |
2019 Q4
11 quarters
|
|
307
Roper Technologies
ROP
$37.8B
| $330K | 0.02% |
917
+129
| +16% | +$52.5K |
2021 Q3
4 quarters
|
|
308
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
| $326K | 0.02% |
4,926
-11
| -0.2% | -$793 |
2020 Q2
9 quarters
|
|
309
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.5B
| $324K | 0.02% |
4,858
-425
| -8% | -$31.1K |
2020 Q4
7 quarters
|
|
310
Aptiv
APTV
$9.38B
| $322K | 0.02% |
4,116
+807
| +24% | +$77.4K |
2021 Q2
5 quarters
|
|
311
EOG Resources
EOG
$80.1B
| $322K | 0.02% |
2,882
+102
| +4% | +$11.4K |
2021 Q1
6 quarters
|
|
312
Moody's
MCO
$83.8B
| $322K | 0.02% |
1,325
+12
| +0.9% | +$3.49K |
2020 Q1
10 quarters
|
|
313
iShares Russell 2000 Value ETF
IWN
$13.8B
| $319K | 0.01% |
2,471
-40
| -2% | -$5.78K |
2020 Q2
9 quarters
|
|
314
iShares Core US Aggregate Bond ETF
AGG
$138B
| $316K | 0.01% |
3,284
-4,010
| -55% | -$406K |
2019 Q4
11 quarters
|
|
315
American Electric Power
AEP
$67.7B
| $313K | 0.01% |
3,626
+56
| +2% | +$5.54K |
2022 Q2
1 quarter
|
|
316
Philip Morris
PM
$312B
| $311K | 0.01% |
3,742
+77
| +2% | +$7.34K |
2013 Q2
37 quarters
|
|
317
iShares S&P Small-Cap 600 Value ETF
IJS
$7.55B
| $310K | 0.01% |
3,758
+2
| +0.1% | +$185 |
2013 Q2
37 quarters
|
|
318
DELISTED
Paramount Global Class B
PARA
| $307K | 0.01% |
16,142
-571
| -3% | -$13.7K |
2020 Q1
10 quarters
|
|
319
Schwab US Broad Market ETF
SCHB
$44.9B
| $300K | 0.01% |
21,465
+1,287
| +6% | +$20K |
2020 Q2
9 quarters
|
|
320
Schwab Fundamental US Large Company Index ETF
FNDX
$28.1B
| $295K | 0.01% |
18,522
+6,159
| +50% | +$109K |
2021 Q2
5 quarters
|
|
|
VMW
321
DELISTED
VMware, Inc
VMW
| $294K | 0.01% |
2,759
-6
| -0.2% | -$691 |
2021 Q4
3 quarters
|
|
322
DELISTED
Warner Bros
WBD
| $288K | 0.01% |
25,035
-2,968
| -11% | -$40.3K |
2022 Q2
1 quarter
|
|
323
Schwab US Dividend Equity ETF
SCHD
$114B
| $283K | 0.01% |
12,801
| – | – |
2021 Q2
5 quarters
|
|
324
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
| $283K | 0.01% |
3,053
+523
| +21% | +$54.4K |
2013 Q2
37 quarters
|
|
325
Petrobras
PBR
$163B
| $271K | 0.01% |
22,000
-47
| -0.2% | -$622 |
2020 Q4
7 quarters
|
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q3 2022 Portfolio in Review
As of Q3 2022, Dowling & Yahnke held 387 positions worth $2.15B, up 1% from $2.13B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Dowling & Yahnke deployed $140M of net new capital in Q3 2022, opening 13 new positions and adding to 178 existing holdings. Its largest new stake was U.S. High Relative Profitability Portfolio ETF Class Shares: 161,010 shares worth $3.44M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $16.8M trimmed.
- Dowling & Yahnke's largest Q3 2022 buy was U.S. High Relative Profitability Portfolio ETF Class Shares: 161,010 shares worth $3.44M.
- Dowling & Yahnke added most to Dimensional International Core Equity Market ETF in Q3 2022, an estimated $30.3M increase.
- Dowling & Yahnke's biggest Q3 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $16.8M.
- Dowling & Yahnke fully exited Saic in Q3 2022, selling an estimated $1.57M.
- Dowling & Yahnke's ten largest holdings make up 30% of its $2.15B portfolio in Q3 2022.
- Dowling & Yahnke opened 13 new positions and closed 14 in Q3 2022.
- Dowling & Yahnke's portfolio value rose 1% quarter-over-quarter to $2.15B.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.